We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

I believe in miracles

28 June 2017 By Olaf Storbeck

The Dutch healthcare equipment maker is buying loss-making US rival Spectranetics for more than 6 times next year’s revenue in a $2.2 bln deal. Ramping up expertise in treating cardiac disease makes strategic sense, but the high price adds unhealthy financial side-effects.

This content is for Subscribers only

To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)